开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Dr .Nidhin
Malignant hyperthermia is a pharmacogenetic
disease triggered in susceptible individuals as a
hypermetabolic response triggered by halogenated
anaesthetics. The incidence of malignant hyperthermia is very
less and the incidence occurring while on-going with renal
transplant is considerably nil. The possibility of witnessing a
malignant hyperthermia perioperative is a nightmare. The
critical nature of the surgery and the on-going disease
process in a paediatric patient makes it cumbersome and
upon which a myoglobinemia, shock, and ischemia play a role
in injuring the transplanted kidney.